Trademark Attorney / Law Firm
James DiPasquale – Trademark Portfolio
James DiPasquale has filed 13 trademarks with the United States Patent and Trademark Office (USPTO). Filing records are from 2022. The portfolio covers 12 Nice Classification classes, with the highest concentration in Class 25 (Clothing, 5 filings) and Class 33 (Wine & Spirits, 4 filings).
Showing of trademarks Trademarks
Practice Areas by Trademark Class
James DiPasquale's trademark practice covers 12 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Machines and machine tools; motors and engines; machine coupling and transmission components
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has James DiPasquale filed?
James DiPasquale has filed 13 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does James DiPasquale specialize in?
James DiPasquale has filed trademarks across 12 Nice Classification classes. The most common practice areas include Class 25 (Clothing), Class 33 (Wine & Spirits), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 25 covers clothing, footwear, headgear.
What is James DiPasquale's trademark registration success rate?
James DiPasquale has a 0% trademark registration rate, with 0 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.